Since 2005, our partner has treated over 1900 patients with Muscular Dystrophy (MD). This is the most of any other condition treated with our largest partner in China. Some of the forms treated include:
- Duchenne Muscular Dystrophy (DMD)
- Becker’s Muscular Dystrophy (BMD)
- Limb-Girdle Muscular Dystrophy
- Facioscapulohumeral Muscular Dystrophy (FSHD)
MD patients not only receive IV injections of stem cells, but also intramuscular injections in order to place the stem cells directly into the atrophied areas. It is important to note that MD is a progressive condition. The first goal of the therapy is to slow the progression of the condition and hopefully relieve some symptoms. The interval between the treatment and the time patients claim improvements have started to regress can vary from patient to patient, but can be as fast as within a year. There is also the possibility of minimal/no improvement, and we encourage patients to keep realistic expectations for the treatment.
General Treatment Protocol:
Below is the general treatment protocol for muscular dystrophy. Please keep in mind that this is only an example and the injection and cell types may change slightly depending on the patient’s condition.
- UCBSC packets injected by IV and intramuscular injection